HOUSTON, May 25 /PRNewswire-FirstCall/ -- Cyberonics, Inc. (Nasdaq: CYBX) today announced that Dan Moore, President and Chief Executive Officer, and Greg Browne, Chief Financial Officer, will present at the Jefferies 2010 Global Life Sciences Conference in New York on Thursday, June 10, 2010 at 3:30 PM EDT. Jefferies will host a webcast of the presentation live and by replay at http://www.wsw.com/webcast/jeff46/cybx/. The conference webcast replay will be available for 90 days following the conference. The conference webcast can also be accessed at www.cyberonics.com by clicking on the link for this webcast. Access to the webcast is not password protected.
About Cyberonics, Inc. and VNS Therapy®
Cyberonics, Inc. (NASDAQ:CYBX) is a medical technology company with core expertise in neuromodulation. The company developed and markets the Vagus Nerve Stimulation (VNS) Therapy System, which is FDA-approved for the treatment of refractory epilepsy and treatment-resistant depression. The VNS Therapy System uses a surgically implanted medical device that delivers pulsed electrical signals to the vagus nerve. Cyberonics markets the VNS Therapy System in approximately 60 countries worldwide, and to date more than 55,000 patients have been implanted with the device.
Additional information on Cyberonics and VNS Therapy is available at www.cyberonics.com.
CONTACT INFORMATION: | |
Greg Browne, CFO | |
Cyberonics, Inc. | |
100 Cyberonics Blvd. | |
Houston, TX 77058 | |
Main: (281) 228-7262 | |
Fax: (281) 218-9332 | |
ir@cyberonics.com | |
SOURCE Cyberonics, Inc.
